Moderna stock has declined by 36.54% over the past year. The past month has seen some recovery in the stock price ... by its reliance on the COVID-19 vaccine as its sole product for customers.

One of the world’s top vaccine-makers is partnering with a major AI company to advance medicine — and its chief executive is excited. Moderna and OpenAI announced an ongoing partnership ...

News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...

Also Read: Moderna’s Next Gen COVID Vaccine Meets Primary Goal In Late-Stage Trial. “Given this, and in alignment with our strategic planning, Moderna believes it is prudent to pause its ...

Moderna claims it is due compensation for products manufactured after March 7 last year. But Pfizer and BioNTech deny infringement, and want two Moderna patents withdrawn as "invalid". The hearing ...

A Victorian coroner is investigating whether a young woman's death from heart inflammation after receiving her third Covid-19 jab was caused by the Moderna vaccine. Moderna's lawyers appeared ...

Shares of Moderna ... vaccine data is interesting. In his words, says the data suggests the vaccine could potentially work in industries outside of melanoma. He has a buy rating, price target ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest ...

It also had plans to start filling doses of its COVID vaccine in the continent as early as 2023. However, Moderna has not received any vaccine orders for Africa since 2022 amid waning demand ...

World Health Organization’s top scientist said this week the recent bird flu outbreak is of “great concern” to public health, and vaccine development ... worse than the COVID-19 pandemic ...

LONDON: A row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday over patents for Covid vaccine technology that helped save millions of lives during the ...